Satter Muneer A 13D and 13G filings for Rein Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-16 5:16 pm Sale |
2024-04-02 | 13D | Rein Therapeutics Inc. RNTX |
Satter Muneer A | 830,466 4.900% |
-186,567 (-18.34%) |
Filing |
| 2024-03-05 4:30 pm Purchase |
2024-03-05 | 13D | Rein Therapeutics Inc. RNTX |
Satter Muneer A | 1,017,033 5.900% |
9,545 (+0.95%) |
Filing |
| 2023-11-03 4:30 pm Purchase |
2023-10-31 | 13D | Rein Therapeutics Inc. RNTX |
Satter Muneer A | 1,007,488 19.900% |
1,007,488 (New Position) |
Filing |